Literature DB >> 11259675

Dwarfism and early death in mice lacking C-type natriuretic peptide.

H Chusho1, N Tamura, Y Ogawa, A Yasoda, M Suda, T Miyazawa, K Nakamura, K Nakao, T Kurihara, Y Komatsu, H Itoh, K Tanaka, Y Saito, M Katsuki, K Nakao.   

Abstract

Longitudinal bone growth is determined by endochondral ossification that occurs as chondrocytes in the cartilaginous growth plate undergo proliferation, hypertrophy, cell death, and osteoblastic replacement. The natriuretic peptide family consists of three structurally related endogenous ligands, atrial, brain, and C-type natriuretic peptides (ANP, BNP, and CNP), and is thought to be involved in a variety of homeostatic processes. To investigate the physiological significance of CNP in vivo, we generated mice with targeted disruption of CNP (Nppc(-/-) mice). The Nppc(-/-) mice show severe dwarfism as a result of impaired endochondral ossification. They are all viable perinatally, but less than half can survive during postnatal development. The skeletal phenotypes are histologically similar to those seen in patients with achondroplasia, the most common genetic form of human dwarfism. Targeted expression of CNP in the growth plate chondrocytes can rescue the skeletal defect of Nppc(-/-) mice and allow their prolonged survival. This study demonstrates that CNP acts locally as a positive regulator of endochondral ossification in vivo and suggests its pathophysiological and therapeutic implication in some forms of skeletal dysplasia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259675      PMCID: PMC31171          DOI: 10.1073/pnas.071389098

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Physiological role of silent receptors of atrial natriuretic factor.

Authors:  T Maack; M Suzuki; F A Almeida; D Nussenzveig; R M Scarborough; G A McEnroe; J A Lewicki
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

Review 2.  Signal transduction by guanylyl cyclases.

Authors:  M Chinkers; D L Garbers
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

Review 3.  Atrial natriuretic factor and related peptide hormones.

Authors:  A Rosenzweig; C E Seidman
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

4.  Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).

Authors:  K J Koller; D G Lowe; G L Bennett; N Minamino; K Kangawa; H Matsuo; D V Goeddel
Journal:  Science       Date:  1991-04-05       Impact factor: 47.728

5.  Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP.

Authors:  V Mericq; J A Uyeda; K M Barnes; F De Luca; J Baron
Journal:  Pediatr Res       Date:  2000-02       Impact factor: 3.756

6.  Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3).

Authors:  J Jaubert; F Jaubert; N Martin; L L Washburn; B K Lee; E M Eicher; J L Guénet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

7.  Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine.

Authors:  F Oberklaid; D M Danks; F Jensen; L Stace; S Rosshandler
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

8.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

9.  C-type natriuretic peptide (CNP) in rats and humans.

Authors:  Y Komatsu; K Nakao; S Suga; Y Ogawa; M Mukoyama; H Arai; G Shirakami; K Hosoda; O Nakagawa; N Hama
Journal:  Endocrinology       Date:  1991-08       Impact factor: 4.736

10.  Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Authors:  S Suga; K Nakao; K Hosoda; M Mukoyama; Y Ogawa; G Shirakami; H Arai; Y Saito; Y Kambayashi; K Inouye
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

View more
  133 in total

Review 1.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

2.  Effect of sialylated O-glycans in pro-brain natriuretic peptide stability.

Authors:  Jingjing Jiang; Nicole Pristera; Wei Wang; Xiumei Zhang; Qingyu Wu
Journal:  Clin Chem       Date:  2010-03-26       Impact factor: 8.327

Review 3.  Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up.

Authors:  Alberto Roselló-Díez; Alexandra L Joyner
Journal:  Endocr Rev       Date:  2015-10-20       Impact factor: 19.871

4.  C-type natriuretic peptide stimulates ovarian follicle development.

Authors:  Yorino Sato; Yuan Cheng; Kazuhiro Kawamura; Seido Takae; Aaron J W Hsueh
Journal:  Mol Endocrinol       Date:  2012-05-17

5.  The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide.

Authors:  S Jeson Sangaralingham; Brenda K Huntley; Fernando L Martin; Paul M McKie; Diego Bellavia; Tomoko Ichiki; Gerald E Harders; Horng H Chen; John C Burnett
Journal:  Hypertension       Date:  2010-12-28       Impact factor: 10.190

Review 6.  Membrane guanylyl cyclase receptors: an update.

Authors:  David L Garbers; Ted D Chrisman; Phi Wiegn; Takeshi Katafuchi; Joseph P Albanesi; Vincent Bielinski; Barbara Barylko; Margaret M Redfield; John C Burnett
Journal:  Trends Endocrinol Metab       Date:  2006-06-30       Impact factor: 12.015

7.  Bi-allelic Loss-of-Function Mutations in the NPR-C Receptor Result in Enhanced Growth and Connective Tissue Abnormalities.

Authors:  Eveline Boudin; Tjeerd R de Jong; Tim C R Prickett; Bruno Lapauw; Kaatje Toye; Viviane Van Hoof; Ilse Luyckx; Aline Verstraeten; Hugo S A Heymans; Eelco Dulfer; Lut Van Laer; Ian R Berry; Angus Dobbie; Ed Blair; Bart Loeys; Eric A Espiner; Jan M Wit; Wim Van Hul; Peter Houpt; Geert R Mortier
Journal:  Am J Hum Genet       Date:  2018-07-19       Impact factor: 11.025

8.  The mRNA-destabilizing protein Tristetraprolin targets "meiosis arrester" Nppc mRNA in mammalian preovulatory follicles.

Authors:  Guangyin Xi; Lei An; Wenjing Wang; Jing Hao; Qianying Yang; Lizhu Ma; Jinlun Lu; Yue Wang; Wenjuan Wang; Wei Zhao; Juan Liu; Mingyao Yang; Xiaodong Wang; Zhenni Zhang; Chao Zhang; Meiqiang Chu; Yuan Yue; Fusheng Yao; Meijia Zhang; Jianhui Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

9.  Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.

Authors:  Naohisa Tamura; Lynda K Doolittle; Robert E Hammer; John M Shelton; James A Richardson; David L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

10.  Phenotypic characterization of the Komeda miniature rat Ishikawa, an animal model of dwarfism caused by a mutation in Prkg2.

Authors:  Atsuko Tsuchida; Norihide Yokoi; Misako Namae; Masanori Fuse; Taku Masuyama; Masashi Sasaki; Shoji Kawazu; Kajuro Komeda
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.